Persson U
Swedish Institute for Health Economics, Lund, Sweden.
Pharmacoeconomics. 1995;8 Suppl 1:28-32. doi: 10.2165/00019053-199500081-00007.
In an attempt to obtain an appropriate estimate of the excess costs of production losses arising from morbidity in patients with diabetes, we compared the number of sick days and permanently disabled individuals in a diabetic population and the corresponding general population. These comparisons show that the rate of premature retirement for both insulin-dependent diabetes mellitus (IDDM, type I diabetes) or non-insulin-dependent diabetes mellitus (NIDDM, type II diabetes) patients was twice that of the average population. Insulin-treated subjects also had twice as many sickness benefit days. The excess costs of production losses as a result of morbidity in people aged 20 to 64 years with type II diabetes were about $US7000 per individual and year. Most of these excess costs were attributed to permanent disability in the 40- to 64-year age groups.
为了对糖尿病患者发病导致的生产损失额外成本进行合理估算，我们比较了糖尿病患者群体和相应普通人群的病假天数及永久残疾人数。这些比较结果显示，胰岛素依赖型糖尿病（IDDM，I型糖尿病）或非胰岛素依赖型糖尿病（NIDDM，II型糖尿病）患者的提前退休率是普通人群的两倍。接受胰岛素治疗的患者领取疾病补贴的天数也为普通人群的两倍。20至64岁的II型糖尿病患者发病导致的生产损失额外成本约为每人每年7000美元。这些额外成本大部分归因于40至64岁年龄组的永久残疾。
